H.M. El Tayebi

Destabilizing the interplay between miR-1275 and IGF2BPs by <i>Tamarix articulata</i> and quercetin in hepatocellular carcinoma

Yasmin M. Shaalan, Heba Handoussa, R.A. Youness et al. · Natural Product Research · 2017 · 65 citations

Medicine, Cancer Biology, Pharmacology +17

miR‐615‐5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma

H.M. El Tayebi, Karim Adel Hosny, Gamal Esmat et al. · FEBS Letters · 2012 · 57 citations

Medicine, Molecular Biology, Oncology +17

XIST and TSIX: Novel Cancer Immune Biomarkers in PD-L1-Overexpressing Breast Cancer Patients

Esraa A. Salama, Reda E. Adbeltawab, H.M. El Tayebi · Frontiers in Oncology · 2020 · 56 citations · Full text

Life Sciences, Immunology, Oncology +17

CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer

Alaa M. Ghallab, Reda A. Eissa, H.M. El Tayebi · Frontiers in Pharmacology · 2022 · 28 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Repression of miR-17-5p with elevated expression of E2F-1 and c-MYC in non-metastatic hepatocellular carcinoma and enhancement of cell growth upon reversing this expression pattern

H.M. El Tayebi, Khalid Omar, S. Hegy et al. · Biochemical and Biophysical Research Communications · 2013 · 26 citations

Medicine, Molecular Biology, Oncology +17